Green Cross MS and Green Cross Laboratories have signed a memorandum of understanding with Thonburi Healthcare Group, a Thai multinational healthcare business.

Under the agreement, Green Cross MS 녹십자MS will supply diagnostic reagents to its partner and Green Cross Laboratories 녹십자의료재단 will cooperate with it to establish a clinical testing service network.

Officials from Green Cross MS, Green Cross Laboratories and Thonburi Healthcare Group pose after signing the agreement

The Green Cross units plan to expand into the Association of Southeast Asian Nations (ASEAN), a rapidly growing market of more than 600 million people, with a strategy that takes different regional export environments into account.

Thailand, the second-largest economy in the ASEAN, spent $25 billion on healthcare in 2014, the largest amount among the 10-nation group.

“We expect our company’s excellent diagnostic and testing technology and services will find sufficient customers in Southeast Asia,” said Lee Eun-hee 이은희, director of Green Cross Laboratories.

Green Cross MS also showed enthusiasm for the cooperative agreement.

“This MOU will likely serve as a bridgehead for the expansion of the market for diagnostic reagents and medical devices of Green Cross MS in the ASEAN market,” said Kim Young-pil 김영필, CEO of Green Cross MS.

Copyright © KBR Unauthorized reproduction, redistribution prohibited